Longterm effect of American ginseng extract (Panax quinquefolius L.) on glycemic control in type 2 diabetic patients
According to previous clinical studies it has been suggested that American ginseng (AG) is effective in improving glycemic control in type 2 diabetes through increasing post-prandial insulin levels, much like the conventional therapy sulphonylurea. The aim of the present study was to test the efficacy and safety of 12 weeks of supplementation with the selected AG extract as an adjunct to usual the…
Contribuitori
- Božikov, Velimir
- Rahelić, Dario
Creator
- Mucalo, Iva
Editor
- University of Zagreb. Faculty of Pharmacy and Biochemistry. Centre for applied pharmacy.
Subiect
- BIOMEDICINE AND HEALTHCARE. Pharmacy. Pharmacy.
- Pharmacology. Therapeutics. Toxicology
- American ginseng
- type 2 diabetes
- glycemic control
- insulin sensitivity
Tipul resursă culturală
- info:eu-repo/semantics/doctoralThesis
- text
Dată
- 2014-07-09
- 2014-07-09
Contribuitori
- Božikov, Velimir
- Rahelić, Dario
Creator
- Mucalo, Iva
Editor
- University of Zagreb. Faculty of Pharmacy and Biochemistry. Centre for applied pharmacy.
Subiect
- BIOMEDICINE AND HEALTHCARE. Pharmacy. Pharmacy.
- Pharmacology. Therapeutics. Toxicology
- American ginseng
- type 2 diabetes
- glycemic control
- insulin sensitivity
Tipul resursă culturală
- info:eu-repo/semantics/doctoralThesis
- text
Dată
- 2014-07-09
- 2014-07-09
Instituție furnizoare
Mențiunea privind drepturile intelectuale privind drepturile intelectuale media pentru această resursă culturală (cu excepția cazului în care se specifică altfel)
- http://rightsstatements.org/vocab/InC/1.0/
Identificator
- https://dr.nsk.hr/islandora/object/pharma:327
- https://urn.nsk.hr/urn:nbn:hr:163:397149
- https://repozitorij.unizg.hr/islandora/object/pharma:327
- https://dr.nsk.hr/islandora/object/pharma%3A327/datastream/TN/view/
Format
- application/pdf
Limbă
- hrv
Țara de proveniență
- Croatia
Numele colecției
Publicat pentru prima dată pe Europeana
- 2019-04-05T13:44:01.832Z
Ultima actualizare de la instituția furnizoare
- 2019-04-05T13:44:01.832Z